/24-7PressRelease/ - MONROVIA, CA, August 09, 2008 - GTCbio just announced its inaugural Bugs & Drugs conference - one of the leading forums to address unmet medical needs for problematic microbials - taking place on September 22-23, 2008 in San Diego, CA.
Infections are becoming increasingly problematic due to the recent resistances to current antibiotics. Patients suffering from resistant bugs (hospital-acquired or community-acquired) now need new yet unavailable treatments to combat their infections.
The Bugs & Drugs conference brings together leading experts to discuss current options available in combating these problematic pathogens and the current drugs in development that may resolve these issues. Included are discussions on various gram positive & negative drugs, contingency plans for biological weapons & disease outbreaks, novel delivery methods, regulatory aspects & clinical trial design, and novel drug developments for diseases of developing economies.
Keynote & featured presenters include Barry Eisenstein, Senior Vice President of Scientific Affairs at Cubit Pharmaceuticals and Clinical Professor of Medicine at Harvard Medical School, Sharath Hegde, Vice President of Pharmacology at Theravance and Rita Helfand, Associate Director of Epidemiologic Science at the National Center for Preparedness, Detection, and Control of Infectious Diseases, the Centers for Disease Control and Prevention.
For more information on attending, presenting a poster, or sponsoring, please visit http://gtcbio.com/conferenceDetails.aspx?id=129.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: Nina Tran, Senior Conference Producer, GTCbio (626) 256-6405, (626) 256-6460 fax, nina.tran@gtcbio.com
# # #
Read more Press Releases from Rania Hafez:- Michael Karin, Professor at UCSD to Give Keynote Speech at 7th Cytokines & Inflammation Conference
- GTCbio Announces its 7th Annual Cytokines & Inflammation Conference
- Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center to Give Keynote Speech at GTCbio's 2nd Oncology Biomarkers Conference on January 19-20 in Miami, Florida
- GTCbio Announces its 2nd Annual Oncology Biomarkers Conference
- Michael Shih, Director of Business Development at Eisai Inc. and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough to Give Joint Featured Presentation at GTCbio's CNS Diseases Partnering & Deal-Making Summit on Dec. 1-2, 2008 in Boston, MA
- GTCBIO ANNOUNCES ITS INAUGURAL CNS DISEASES PARTNERING & DEAL-MAKING SUMMIT
- Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- Herbert Fritsche, Professor and Chief of Clinical Chemistry at MD Anderson Cancer Center to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
- Mike Romanos, Vice President of Discovery Technologies at GlaxoSmithKline to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
- Sharath Hegde, Vice President at Theravance to Give Featured Presentation at GTCbio's Bugs & Drugs Conference on September 22-23, 2008 in San Diego, CA
